Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

192.23B

Market cap192.23B

Price-Earnings ratio

10.13

Price-Earnings ratio10.13

Dividend yield

2.85%

Dividend yield2.85%

Average volume

12.66M

Average volume12.66M

High today

$43.50

High today$43.50

Low today

$42.52

Low today$42.52

Open price

$43.46

Open price$43.46

Volume

9.00M

Volume9.00M

52 Week high

$74.38

52 Week high$74.38

52 Week low

$35.12

52 Week low$35.12

NVO News

Simply Wall St 7h

Novo Nordisk Faces Cyber Breach While Pushing Oral Wegovy Into China

Novo Nordisk (NYSE:NVO) reported a material cybersecurity breach involving stolen patient, clinical, and proprietary data that attackers are seeking to monetize...

Simply Wall St 7h

Why Hims & Hers Health Is Up 32.3% After Novo Nordisk GLP-1 Deal And Telehealth Push

In recent weeks, Hims & Hers Health has secured a partnership with Novo Nordisk to offer GLP-1 weight-loss drugs, completed the acquisition of digital health pl...

Nasdaq 11h

Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock?

Key Points Novo Nordisk was the first to market with a GLP-1 weight-loss drug. It lost its early lead to Eli Lilly, which is now the name to beat in the GLP-1...

Analyst ratings

51%

of 37 ratings

Buy

40.5%

Hold

51.4%

Sell

8.1%

More NVO News

TipRanks 1d

Novo Nordisk Stock Climbs as Analyst Flags Potential for More Wegovy Pill Sales - TipRanks

...

Simply Wall St 1d

Novo Nordisk Stock Could Be 54.5% Undervalued After Its 90 Day Rebound

Novo Nordisk (NVO) continues to draw investor attention after recent share price moves, with the stock last closing at $43.19. The company’s performance metrics...

TipRanks 2d

Novo Nordisk upgraded to Buy from Hold at Nordea

Nordea upgraded Novo Nordisk (NVO) to Buy from Hold with a DKK 350 price target The firm believes the near-term news flow “looks positively skewed.” Nordea sees...

TipRanks 2d

Novo Nordisk Stock Jumps as Owner Launches Obesity Research Network

Danish drugmaker Novo Nordisk’s (NVO) shares in Copenhagen rose about 5% on Friday. This coincides with Novo Nordisk Foundation, the company’s majority owner, l...

Nasdaq 3d

Novo Nordisk Faces Alleged Data Theft After Cyber Extortion Group Claims Massive Breach

(RTTNews) - Novo Nordisk B A/S (NVO), the Danish pharmaceutical firm, has announced it's looking into claims made by the cyber extortion group FulcrumSec, which...

Benzinga 3d

Novo Nordisk Data Breach: Hackers Claim To Have Stolen Drug Research, Trial Data And AI Models

FulcrumSec Claims Months-Long Access To Company Systems Citing a message posted by FulcrumSec on Tuesday, Reuters reported that the group spent more than two m...

TipRanks 3d

Novo Nordisk’s Iraq Haemophilia Study Adds Real‑World Support for Turoctocog Alfa

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.